Chris Quirk
Follow
Get notifications in MyBN when activity occurs.
Chris Quirk
Dr Chris Quirk is an Australian dermatologist who has been a teaching hospital consultant for 29 years and has conducted numerous trials for international pharmaceutical companies such as Roche, Novartis, 3M and Matrix. He served on advisory boards for Merck, Allergan and Roche, Abbott, Wyeth and Janssen. Dr Quirk published 22 papers in international journals and has presented at several international conferences.
Person Activity
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Medical Director | | 2004 - 2024 | |
| Director | | 2006 - 2017 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Wellfully | 30 Apr 2020 | Other | 1,158,831 | OtherOff-market transfer: Assuming 1,158,831 Indirect shares transferred to Direct shares. | ||
| Wellfully | 30 Apr 2020 | Other | 1,158,831 | OtherOff-market transfer: Assuming 1,158,831 Indirect shares transferred to Direct shares. | ||
| Wellfully | 31 Aug 2017 | Bought | 5,000,000 | OtherConversion of securities | ||
| Wellfully | 31 Aug 2017 | Other | 5,000,000 | OtherConversion of securities: 10,000,000 - Performance Rights | ||
| Wellfully | 02 Nov 2015 | Issued | 87,719 | $0.06 | $5,000 | Rights issue |
Powered by Morningstar ®
